• Helping you understand who owns the world, and how you can invest in it.
  • Follow us

Vir Biotechnology, Inc.

Vir Biotechnology, Inc.

Public
VIR
United States
SectorHealthcare
CountryUnited States
Market cap1.74B
A clinical-stage immunology company developing advanced treatments for serious infectious diseases.

Where to buy Vir Biotechnology, Inc. (VIR)

VIR trades on these platforms. Substox may earn a commission if you open an account through one of these links, at no cost to you. It never changes what the data on this page says. Substox is not a licensed financial adviser and this is not investment advice.

Similar public companies in Healthcare